MAIA Biotechnology (MAIA) Other Accumulated Expenses (2021 - 2026)
MAIA Biotechnology's Other Accumulated Expenses came in at $366,044 for Q2 2026, up 5.6% from $346,538 a year earlier and up 12.4% from the prior quarter.
Powered by 
Analysis
MAIA Biotechnology (MAIA) Other Accumulated Expenses (2021 - 2026) Analysis & Trends
At the end of FY2025, MAIA Biotechnology's Other Accumulated Expenses was $248,066, up 13.9% from FY2024.
- Other Accumulated Expenses carries a four-year compound annual growth rate of 22.2% (FY2021 to FY2025).
- Going back by year, Other Accumulated Expenses was $217,832 in FY2024 (-64.3%), $610,393 in FY2023 (+283.2%), $159,269 in FY2022 (+43.1%) and $111,271 in FY2021.
- The Q2 2026 figure represents the highest quarterly Other Accumulated Expenses since Q4 2023.
- Year-over-year, Other Accumulated Expenses has increased for six consecutive quarters, with an average decline of 3.2% over the last eight quarters.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q3 2023 (growth of 997.3%), and the weakest in Q4 2024 (a decline of 64.3%).
- Business Quant data shows MAIA's Other Accumulated Expenses at $325,662 (Q1 2026), $248,066 (Q4 2025) and $341,187 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn |
| 10 | MAIA Biotechnology | 69.78 Mn | -11.78 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 366,044.00 |
| Mar 31, 2026 | 325,662.00 |
| Dec 31, 2025 | 248,066.00 |
| Sep 30, 2025 | 341,187.00 |
| Jun 30, 2025 | 346,538.00 |
| Mar 31, 2025 | 309,257.00 |
| Dec 31, 2024 | 217,832.00 |
| Sep 30, 2024 | 313,878.00 |
| Jun 30, 2024 | 317,129.00 |
| Mar 31, 2024 | 259,686.00 |
| Dec 31, 2023 | 610,393.00 |
| Sep 30, 2023 | 409,971.00 |
| Jun 30, 2023 | 197,211.00 |
| Mar 31, 2023 | 162,251.00 |
| Dec 31, 2022 | 159,269.00 |
| Sep 30, 2022 | 37,361.00 |
| Jun 30, 2022 | 114,333.00 |
| Dec 31, 2021 | 111,271.00 |
API Access
MAIA Biotechnology Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=MAIA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "MAIA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=MAIA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();